Dechra (the maker of Vetoryl) has launched 'Prime Suspects', a nationwide campaign to raise awareness of Cushing’s syndrome amongst dog owners and drive them to vet practices for diagnosis and treatment.

The company points to a survey of 1000…

Dechra has created a new app with the Royal Veterinary College which promises to help vets better diagnose and treat endocrine disorders in companion animals. 

Typically, diagnosis of endocrine disease is based on a thorough history and physical examination…

Dechra will be hosting two CPD sessions at the London Vet Show, the first about why senior cat health checks are worthwhile and the second covering the Nordic approach to antibiotic usage in otitis external.

‘Feline enthusiasts assemble! How to help senior…

Dechra has launched Fluboral (flubendazole), a water-soluble wormer for chickens and pigs.

Fluboral controls gastro-intestinal nematodes including Ascaridia galli (adult stages), Heterakis gallinarum (adult stages) and Capillaria spp. (adult stages) in…

Dechra has launched a range of resources to provide vets and owners with education, tips and support to achieve better clinical outcomes and owner satisfaction for dogs with otitis externa.

The 'Lifelong Ear Partnership' resources, which were developed…

Dechra has launched Equisolon Jar, a new presentation of its oral prednisone powder for the treatment of severe equine asthma.

Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters…

Dechra has published the results of a survey which shows how vets and horse owners could do more to prevent strangles. 

The survey of 50 vets carried out in May this year¹ found that only half of them are recommending strangles vaccination to their clients…

Dechra, maker of Mirataz, is hosting a feline inappetence breakfast meeting at the ISFM Feline Congress at The Clayton Hotel in Dublin at 7.15am on Saturday 1st July to update vets on the practical management of inappetence in cats.

The one hour ‘Wake…

Dechra has taken over the distribution of two products designed to support kidney health in senior cats, Porus One and its sister product Add One.

Porus One contains renaltec, a selective absorber that absorbs the precursors of uraemic toxins in the cat…

Dechra is conducting a survey about strangles to better understand veterinary surgeons' approach to managing the disease.

The survey will assess vets’ experiences of the disease, biosecurity and the role of vaccination to help prevent strangles.…

Dechra, the maker of Mirataz, is hosting a free webinar: ‘Feline pawsative about feline inappetence?’, at 8:00pm tonight.

Presented by Sam Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, the webinar will also be available to watch on…

Dechra has relaunched Sedaxylan 20 mg/ml solution for the sedation and premedication prior to general anaesthesia of dogs, cats, horses and cattle.

Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for I/V administration…

Dechra has launched Zenalpha, an alpha-2 agonist and peripheral antagonist combination to alleviate the stress of sedation in dogs and maintain the stability of physiological parameters¹.

Zenalpha provides restraint, sedation and analgesia during non…

Dechra has launched Dexacortone (dexamethasone 0.5 mg and 2 mg), a long-acting glucocorticosteroid for the symptomatic treatment of inflammatory and allergic conditions in cats and dogs.

Dechra says that Dexacortone, which is presented as a flavoured double…

Dechra has launched Equibactin Powder (25mg sulfadiazine and 5mg trimethoprim), a new antibiotic powder designed to help prevent the under-dosing of larger horses being treated for bacterial infections.

Equibactin oral powder comes in a 60g sachet, which…

Dechra has launched a 9g sachet version of its prednisolone treatment, Equisolon, for horses with severe equine asthma.

The oral corticosteroid powder formulation was previously only available in 180g tubs.

Severe equine asthma, which was previously known…